These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 33455848)
1. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. Wongsalap Y; Kengkla K; Poolpun D; Saokaew S J Cardiol; 2021 Jun; 77(6):669-676. PubMed ID: 33455848 [TBL] [Abstract][Full Text] [Related]
2. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China. He X; Wang Y; Cong H; Lu C; Wu J Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126 [TBL] [Abstract][Full Text] [Related]
3. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study. Iannaccone M; D Ascenzo F; De Filippo O; Gagliardi M; Southern DA; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Moretti C; Gaita F; Kalpak O; Kedev S Am J Cardiovasc Drugs; 2017 Feb; 17(1):61-71. PubMed ID: 27738920 [TBL] [Abstract][Full Text] [Related]
4. Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting. Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):102-110. PubMed ID: 29394340 [TBL] [Abstract][Full Text] [Related]
5. Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry. Cirillo P; Di Serafino L; Taglialatela V; Calabrò P; Antonucci E; Gresele P; Palareti G; Patti G; Pengo V; Pignatelli P; Marcucci R Angiology; 2020 Mar; 71(3):235-241. PubMed ID: 31867981 [TBL] [Abstract][Full Text] [Related]
6. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction. Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806 [TBL] [Abstract][Full Text] [Related]
7. Evidence-Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention. Lee K; Han S; Lee M; Kim DW; Kwon J; Park GM; Park MW J Am Heart Assoc; 2023 May; 12(10):e024370. PubMed ID: 37158100 [TBL] [Abstract][Full Text] [Related]
8. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome. Wongsalap Y; Jedsadayanmata A J Cardiol; 2020 Mar; 75(3):275-281. PubMed ID: 31519405 [TBL] [Abstract][Full Text] [Related]
9. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar. El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397 [TBL] [Abstract][Full Text] [Related]
10. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896 [TBL] [Abstract][Full Text] [Related]
11. The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study. Zhang D; Song X; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; D'Ascenzo F; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Alexopoulos D; Liebetrau C; Kawaji T; Moretti C; Huczek Z; Nie S; Fujii T; Correia L; Kawashiri MA; Southern D; Kalpak O Int J Cardiol; 2020 Nov; 318():1-6. PubMed ID: 32598995 [TBL] [Abstract][Full Text] [Related]
12. Optimal medical therapy, clinical outcome and its predictors in patients with acute coronary syndrome after discharge with secondary prevention medications at University of Gondar Comprehensive Specialized Hospital, North West Ethiopia, 2023: A retrospective follow-up study. Geremew GW; Alemayehu TT; Bekalu AF; Mengistu ME; Anberbr SS; Getahun AD; Fentahun S; Tadesse G; Wassie YA BMC Cardiovasc Disord; 2024 Oct; 24(1):533. PubMed ID: 39363265 [TBL] [Abstract][Full Text] [Related]
13. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease. Perera D; Crake T; Lee V Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315 [TBL] [Abstract][Full Text] [Related]
14. Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry. Hoedemaker NPG; de Winter RJ; Hof AV; Kolkman E; Damman P Am J Cardiovasc Drugs; 2021 Mar; 21(2):219-229. PubMed ID: 32783182 [TBL] [Abstract][Full Text] [Related]
15. Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies. Sun Y; Xie G; Patel A; Li S; Zhao W; Yang X; Wu T; Li M; Li X; Du X; Hu R; Huo Y; Hu D; Gao RL; Wu Y Clin Cardiol; 2018 Sep; 41(9):1192-1200. PubMed ID: 30084224 [TBL] [Abstract][Full Text] [Related]
16. Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China. Zhang J; Hao JY; Jing R; Liu JJ; Di CY; Lu YJ; Gao P; Wang YJ; Yang RF; Lin WH BMC Cardiovasc Disord; 2021 May; 21(1):258. PubMed ID: 34039268 [TBL] [Abstract][Full Text] [Related]
17. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514 [TBL] [Abstract][Full Text] [Related]
18. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS]. Yahia DH; Pereg D; Lishner M; Elis A Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639 [TBL] [Abstract][Full Text] [Related]
19. Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan. Ahmed KO; Ahmed AM; Wali MB; Ali AH; Azhari MM; Babiker A; Yousef BA; Muddather HF Ther Clin Risk Manag; 2022; 18():391-398. PubMed ID: 35431548 [TBL] [Abstract][Full Text] [Related]
20. The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease. Chen SJ; Liu W; Huang BT; Tsauo JY; Pu XB; Peng Y; Chen M; Huang DJ J Geriatr Cardiol; 2017 Feb; 14(2):100-107. PubMed ID: 28491084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]